The object is to provide an SNRI-containing preparation which has a higher absorbability compared to a conventional SNRI preparation, produces its effect rapidly, and is readily administered to a patient who is hard to be administered via an oral route. Disclosed is a preparation for transmucosal administration, comprising a selective serotonin/noradrenaline reuptake inhibitor and a thickening agent.